Approved indications (U.S.)
Oral nystatin is approved for treatment of Candida infections of the oral cavity (oral thrush) and for intestinal candidiasis; topical nystatin is approved for cutaneous and mucocutaneous candidiasis, including diaper rash and intertrigo due to Candida species.

Common off-label uses
Clinicians may use nystatin topically for prophylaxis of candidal diaper rash or other recurrent superficial Candida infections, and oral formulations may be used for prophylaxis in certain high‑risk patients (for example some immunocompromised or antibiotic‑treated patients), though evidence and practice patterns vary and systemic azoles are often preferred for more extensive disease.

Efficacy expectations
For mild to moderate oral thrush or superficial skin Candida infections, symptom improvement often begins within a few days, with typical treatment courses lasting 7–14 days; clinical cure rates are generally high when the drug is used correctly and underlying risk factors are addressed. Compared with systemic antifungals such as fluconazole, nystatin is confined to the site of application (it is not significantly absorbed), making it very effective for localized mucocutaneous candidiasis but not for deep or systemic infections; other topical azoles (e.g., clotrimazole, miconazole) have similar efficacy, and choice often depends on formulation preferences and local resistance patterns.

Typical dosing and how to take/use
For oral candidiasis, adults and children often use 400,000–600,000 units of nystatin oral suspension four times daily, or equivalent tablet doses, usually swished and held in the mouth as long as possible before swallowing; infants are typically given smaller volumes applied to the inside of the mouth after feeds as directed by a clinician. For intestinal candidiasis, similar unit doses may be swallowed without the need for prolonged contact with the mouth. For topical skin or diaper area infections, creams, ointments, or powders are usually applied in a thin layer to clean, dry affected areas 2–4 times daily, often after each diaper change in infants, and used for several days after symptoms resolve.

Special instructions
Oral suspension is usually shaken well before use and measured with a dosing device, not a household spoon; patients should avoid eating or drinking immediately after dosing when treating oral thrush to maximize contact time. For topical products, avoid contact with eyes, and do not apply inside the mouth, vagina, or other mucosal surfaces unless the product is specifically labeled for that use; avoid covering large areas with airtight dressings unless instructed, to reduce excessive moisture and irritation.

Missed dose guidance
If a dose is missed, take or apply it as soon as remembered unless it is almost time for the next dose, in which case skip the missed dose and resume the regular schedule; do not double up to make up for a missed dose.

Overdose
Accidental ingestion of modest extra amounts of oral nystatin is unlikely to cause serious systemic toxicity in most people due to poor absorption, but large ingestions (especially in children) can cause significant nausea, vomiting, or diarrhea and warrant contacting a poison control center or seeking medical care; topical over‑application typically causes local irritation and should be washed off with water.

Common side effects
With oral suspension or tablets, common effects include mild nausea, stomach upset, diarrhea, and unpleasant taste, usually starting soon after doses and often resolving as treatment continues or after stopping. With topical creams, ointments, or powders, mild skin irritation, burning, itching, or redness at the application site can occur; these are typically mild and transient.

Serious or rare adverse effects
Serious reactions are uncommon because nystatin is minimally absorbed, but allergic reactions can occur, including rash, hives, swelling of the face, lips, tongue, or throat, severe dizziness, or trouble breathing—these require immediate medical attention. Very rarely, severe skin reactions or marked gastrointestinal distress can occur with oral use; persistent vomiting, severe abdominal pain, or blood in stool should prompt urgent evaluation.

Warnings and precautions
Because nystatin is not significantly absorbed from the gut or intact skin, systemic toxicity is rare, but caution is advised in anyone with a known hypersensitivity to nystatin or formulation ingredients. In pregnancy and breastfeeding, nystatin is generally considered low risk and is commonly used for localized candidiasis when needed; patients should still discuss individual situations with their clinician. No specific dose adjustment is usually required for kidney or liver disease due to minimal systemic absorption, but severe mucosal disease may warrant evaluation for systemic therapy. Use in infants and children is common for thrush and diaper rash, but dosing and application should follow pediatric instructions to avoid choking (with oral suspension) and excessive application under occlusive diapers.

Relative safety compared with other drugs
Nystatin is considered one of the safer antifungals for localized mucocutaneous Candida infections because it stays mainly where it is applied and does not typically affect the rest of the body, unlike systemic azoles that can affect the liver and interact with many drugs.

Reporting side effects and safety updates
Patients in the United States can report suspected side effects to the FDA MedWatch program (online or by phone) and should ask their pharmacist or clinician where to find the most current medication guide or safety communications for nystatin.

Drug and product interactions
Because nystatin has minimal systemic absorption, it has very few clinically significant interactions with other prescription or over‑the‑counter drugs, supplements, or foods. However, using other topical products (steroids, antibacterial creams, barrier ointments, powders) on the same area can dilute or wash off nystatin or increase irritation, so application schedules may need spacing. Alcohol has no specific interaction with nystatin at usual doses, but heavy use can impair immunity and wound healing.

Precautions and conditions affecting use
Use with caution in anyone with known allergy to polyene antifungals (e.g., amphotericin B) or excipients in the formulation. Persistent or recurrent candida infections may indicate underlying conditions such as diabetes, immunosuppression, or poorly fitting dentures, which should be evaluated and addressed. Topical nystatin should not be used for bacterial or viral skin infections, as it will not be effective and may delay proper treatment.

Monitoring needs
No routine blood tests, ECGs, or systemic monitoring are usually required for otherwise healthy patients because of the lack of significant systemic absorption. Clinical monitoring focuses on symptom improvement within several days, resolution of lesions by the end of therapy, and watching for local irritation or signs of allergy; lack of response should prompt reassessment of diagnosis, adherence, and need for alternative or systemic antifungal therapy.

Q: How long does it take for nystatin to start working?
A: Many people notice improvement in discomfort and appearance of oral thrush or skin yeast infections within a few days, but it is important to keep using nystatin for the full prescribed course, often 7–14 days, or a few days after symptoms clear.

Q: Can I use nystatin on my baby’s diaper rash?
A: Nystatin creams or ointments are commonly used for diaper rashes caused or complicated by Candida yeast; apply a thin layer to clean, dry skin as directed by your child’s clinician, usually after each diaper change, and seek medical advice if the rash worsens or does not improve in a few days.

Q: Is nystatin safe to use during pregnancy or breastfeeding?
A: Nystatin is generally considered low risk during pregnancy and breastfeeding when used on the skin or in the mouth, because it is poorly absorbed into the bloodstream, but you should always confirm with your obstetric provider before starting any medicine.

Q: Can nystatin treat vaginal yeast infections?
A: Standard topical nystatin products for skin or oral use are not all intended for vaginal application, but specific nystatin vaginal formulations (not always available in every region) can treat vaginal Candida infections; many clinicians prefer azole antifungal creams or suppositories for this purpose.

Q: What should I do if nystatin is not clearing my infection?
A: If symptoms are not improving after several days, or if they recur quickly, contact your clinician to confirm the diagnosis, check for underlying problems (such as diabetes, denture fit, or immune issues), and discuss whether an alternative or systemic antifungal such as an azole might be more appropriate.

Storage
Store nystatin tablets, suspension, creams, ointments, and powders at room temperature away from excess heat, moisture, and direct light, and keep the container tightly closed and out of reach of children and pets; do not freeze the oral suspension unless the product label specifically allows it.

Disposal
Do not flush nystatin down the toilet or pour it into drains unless instructed; instead, use a community drug take-back program if available or follow local guidance for household trash by mixing leftover medicine with an unappealing substance (such as coffee grounds or cat litter), sealing in a bag or container, and discarding in the trash.